>>Modified Nucleotides>>Pseudo-UTP,100mM Tris Solution

Pseudo-UTP,100mM Tris Solution (Synonyms: Pseudouridine-5'-Triphosphate, 5-Ribosyl Uracil)

Catalog No.GB20003

Pseudo-UTP is a modified UTP derived through base isomerization reaction and is often used for drug synthesis of mRNA.

Products are for research use only. Not for human use. We do not sell to patients.

Pseudo-UTP,100mM Tris Solution Chemical Structure

Size 가격 재고 수량
10ul
US$40.00
재고 있음
50ul
US$120.00
재고 있음
100ul
US$180.00
재고 있음
1mL
US$650.00
재고 있음
10mL Please Inquire Please Inquire
100mL Please Inquire Please Inquire
500mL
US$0.10
Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Pseudo-UTP is derived from UTP through base isomerization reaction, which can perform complementary base pairing with adenosine like uridine, and change the structure of RNA by improving base pairing, base stacking and main chain stability [1]. The mRNA in which Pseudo-UTP completely replaces UTP exhibits lower immunogenicity, higher stability and translation ability [2].

References:
[1]. Yi-Tao Yu. RNA-guided isomerization of uridine to pseudouridine-pseudouridylation. Clin Chim Acta. 2014;11(12):1483-94. doi: 10.4161/15476286.2014.972855. PMCID: PMC4615163.
[2]. Muthian Shanmugasundaram, et al. An Efficient Protection-Free One-Pot Chemical Synthesis of Modified Nucleoside-5'-Triphosphates. Nucleosides Nucleotides Nucleic Acids. 2016 Jul 2;35(7):356-62.

리뷰

Review for Pseudo-UTP,100mM Tris Solution

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pseudo-UTP,100mM Tris Solution

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.